Click here to read about some of the people we've helped.  We're here to help you, too. Get four essential health reports when you join our e-news community.

FREE REPORT. Your key pointers to a life-transforming diet

Find out the best diet for you in one of four free reports we'll give you when you join the WDDTY community. We'll also send you up-to-the-moment health news and advice twice a week, packed full of insights that may well transform your own health.

First Name:Email:


Avandia: Now the shareholders are suing the drug co

Drug companies are sometimes sued by surviving relatives after a loved one has died after taking one of their toxic products – but now shareholders are getting in on the act.

Shareholders of GlaxoSmithKline (GSK) are preparing an investor class action lawsuit over “false and misleading statements” made by the drug company about its diabetes drug, Avandia.

It’s only recently been revealed that GSK’s blockbuster drug increases the chances of congestive heart failure by 45 per cent.  Since the alert was published, GSK shares have fallen 10 per cent.

But shareholders are claiming that GSK was aware of the drug’s dangers back in 2005, but never released the data.  Instead, the initial analysis was sent to the drug industry’s friend, the Food and Drug Administration (FDA), which, of course, sat on the data for two years.

Investors who bought shares between October 2005, when GSK sent the initial research findings to the FDA, and last May, when the risks of the drugs were finally publicised, may be included in the suit.

(Source:  The Guardian, June 13, 2007).


E-news broadcast 14 June 2007 No.368
[Subscribe]


Share this article:
del.icio.us | Digg it | ma.gnolia | Newsvine | Onlywire | reddit | Netscape | StumbleUpon


WDDTY Blog Speak

Drug Secrecy: GSK threatened career of whistle-blower - GlaxoSmithKline (GSK), the drug company, threatened to either sue or ruin the career of a medical researcher who spoke out against its diabetes drug A...

Avandia: New study confirms it’s a high-risk drug - Avandia, the best-selling diabetes drug, has had the final nail driven into its coffin. It’s just as dangerous as everyone feared, a new study has co...

Drug companies: mea culpa - Drug manufacturer Glaxo is in trouble with the US Food and Drug Administration over its advertising of Zantac (ranitidine), a treatment for peptic ulc...

Diabetes drug banned in the uk - A new drug for diabetes, troglitazone (Romozin), has been declared unsafe and banned in Britain. The decision has come after six people died and numer...

Losing Weight: The pills don’t work, but still the drug companies push them - Can you lose weight just by popping a slimming pill? Needless to say, the drug companies think so, and they’re in the process of making the best-sell...

Avandia: It stays on the market despite new evidence of heart risk - Better safe than sorry is clearly not the motto of American’s drug ‘watchdog’, the Food and Drug Administration (FDA), after it allowed the anti-diabe...

Avandia: So. . . how exactly did it get approved in the first place? - The sudden safety alert from America’s drugs regulator, the Food and Drug Administration (FDA), about the diabetes drug Avandia leaves two vital quest...

WHO Does What? Health organization takes illicit donations from drug companies, report claims - The World Health Organization (WHO) – supposedly an independent voice of global health - is accepting illicit payments from drug companies, a new repo...